Sato A, Arai S, Sumi K, Fukamachi H, Miyake S, Ozawa M, et al
This contributes to increased satiety and reduced appetite, which may support weight managementa beneficial effect for many individuals with type 2 diabetes, though the medication is not licensed for weight loss
The addition of glucagon-receptor activity to the dual-incretin mechanism (already represented by compounds such as tirzepatide) is hypothesized in the literature to extend the molecule's effects on hepatic lipid handling and energy expenditure beyond what is observed with GLP-1/GIP co-agonism alone
The results of semaglutide are long-lasting as long as you maintain a healthy diet and lifestyle
Guo H, Yang J, Huang J, Xu L, Lv Y, Wang Y, et al